Newsroom - Page 2

A series of papers in The Lancet highlights how city planning and urban design can prevent chronic diseases and create healthier and more sustainable cities.
Access to, and levels of spending on, prescription drugs has become an important public policy issue. The development and implementation of patient-centered solutions that allow access to medications at an affordable cost are of critical importance.
The American Association for the Study of Liver Diseases/Infectious Diseases Society of America Guidance Panel is recommending that before patients begin antiviral therapies for the treatment of hepatitis C, that they be screened for hepatitis B, as well.
What we're reading, September 26, 2016: the obesity rate in America has been rising steadily, but the health system is ill equipped to treat these patients; the pros and cons of mail-order medications; and barring recipients of federal funding from preventing money from going to Planned Parenthood.
AbbVie’s blockbuster arthritis medication, adalimumab (Humira), now has an FDA-approved competitor: Amgen’s adalimumab-atto, also called Amjevita.
Older fee-for-service Medicare beneficiaries with dementia who have lower levels of continuity of care have higher rates of hospitalization, emergency department visits, testing, and healthcare spending.
Under the Affordable Care Act, health centers received federal funding to provide comprehensive primary care to patients in underserved communities. An analysis of Medicaid claims data in 13 states has found that these health centers reduced spending by 24% per Medicaid patient.
An ongoing clinical trial has shown that the use of a recently approved hepatitis C virus (HCV) medication could make it possible to transplant HCV-infected kidneys into non-infected patients.
Diabetes Compendium
HCV Compendium
Oncology Compendium
Reimbursement Compendium
Know Your News
HF Compendium